Coronavirus IgM/IgG Antibody Detection Card

Alternate Name : Coronavirus IgM/IgG Antibody Detection Card; SARS-CoV-2 Coronavirus IgM/IgG Antibody Detection Card, 2019-nCoV Coronavirus Antibody Detection Card, Novel Coronavirus 2019 Detection Card

Tag Line :

Antibody Based Detection Card to detect SARS-CoV-2

Storage Conditions: 4ºC

Shelf life: 12 moths

Summary :

BioVision’s Coronavirus (SARS-CoV-2) IgM/IgG Antibody Detection Card is used for the qualitative, in vitro detection of IgM and IgG antibodies against the novel Coronavirus (Sars-Cov-2) in human serum, plasma, whole blood or fingertip blood. The detection is based on the colloidal gold immune-technology for detecting novel Coronavirus IgM and IgG antibodies. The Test Card contains a nitrocellulose membrane and a combination card. The detection area of the nitrocellulose membrane is coated with mouse anti-human IgG and mouse anti-human IgM antibodies and the control area is coated with rabbit anti-chicken IgY. The combination card comprises of sprayed colloidal gold labeled recombinant novel coronavirus antigen and chicken IgY, sample pad, absorbent pad and a PVC soleplate. If the sample contains the novel Coronavirus IgM and IgG antibodies, these antibodies will bind to the gold labeled virus antigen. The binding of antibodies in the sample to the antigen forms a sandwich immune complex with the coated anti-human IgM and IgG monoclonal antibodies, which develops a purplish red color indicating that the novel Coronavirus antibodies are present in the sample. BioVision offers the IgM/IgG Antibody Detection Card for researchers to quickly detect Coronavirus in samples and aid in research on CoronaVirus.

Detection Method: Detection of IgM and IgG antibodies against the novel Coronavirus (Sars-Cov-2)

Features & Benefits:

Direct observation without any instruments,Rapid, easy and convenient,High sensitivity and specificity,Obtain results in 3-15 min

Description:

BioVision’s Coronavirus (SARS-CoV-2) IgM/IgG Antibody Detection Card is used for the qualitative, in vitro detection of IgM and IgG antibodies against the novel Coronavirus (Sars-Cov-2) in human serum, plasma, whole blood or fingertip blood. The detection is based on the colloidal gold immune-technology for detecting novel Coronavirus IgM and IgG antibodies. The Test Card contains a nitrocellulose membrane and a combination card. The detection area of the nitrocellulose membrane is coated with mouse anti-human IgG and mouse anti-human IgM antibodies and the control area is coated with rabbit anti-chicken IgY. The combination card comprises of sprayed colloidal gold labeled recombinant novel coronavirus antigen and chicken IgY, sample pad, absorbent pad and a PVC soleplate. If the sample contains the novel Coronavirus IgM and IgG antibodies, these antibodies will bind to the gold labeled virus antigen. The binding of antibodies in the sample to the antigen forms a sandwich immune complex with the coated anti-human IgM and IgG monoclonal antibodies, which develops a purplish red color indicating that the novel Coronavirus antibodies are present in the sample. BioVision offers the IgM/IgG Antibody Detection Card for researchers to quickly detect Coronavirus in samples and aid in research on CoronaVirus.